Can Eating Avocado and Mango Every Day Help With Prediabetes?
In adults with prediabetes, a daily avocado and a cup of mango, eaten in place of refined, low-fiber foods, improved a measure of how well their blood vessels worked after eight weeks. Fasting blood sugar didn't differ significantly between groups, so the pair looks like a smart food swap with a possible vascular upside. It isn't a proven glucose treatment. If you enjoy both, putting them where refined grains or sweets used to be fits this trial and current diabetes guidance. Whether this exact combination protects against diabetes or heart disease is still untested.
Fruit trials looking at blood-vessel health have produced mixed results, and whether this particular fruit pair helps the vessels of people who already have prediabetes has been uncertain. A randomized trial published in February 2026 in the Journal of the American Heart Association tested that question.
A two-point gap, and where it came from
The trial randomized 82 adults with prediabetes. One group got weekly diets that included a medium Hass avocado and a cup of fresh mango every day. The other got the same calories from low-fat, low-fiber refined carbohydrate foods. Feeding was only partially controlled, so participants ate some of their own food too. The main outcome was flow-mediated dilation (FMD), a standard ultrasound measure of how readily the artery in your upper arm widens when blood flow increases. It reflects how well the vessel lining is working, and it isn't a count of heart attacks or strokes prevented.
After adjusting for baseline values, FMD ended up about 2 percentage points better in the fruit group than in the control group, a statistically significant difference. The split matters. FMD rose about 0.9 point on avocado and mango and fell about 1.2 points on the refined-food diet, so more than half the gap came from the control group getting worse. That makes the comparison fruit versus low-fiber refined foods, which is the relevant comparison if refined snacks are what the fruit would replace in your own diet. It also means the trial can't say how much a daily avocado and mango would help someone whose diet is already good.
Some caveats travel with that number. Only about four in five of the 82 people contributed usable vascular measurements, and two who dropped out late had their earlier readings carried forward. The trial ran eight weeks. It was funded by unrestricted grants from the National Mango Board and the Hass Avocado Board, which according to the study announcement had no role in the design or findings. None of this erases the result, though it's reason to treat the size of the effect as preliminary.
Fruit, fiber, or this particular pair?
Several things changed at once. People in the fruit group ate more total fruit, fiber, vitamin C, and monounsaturated fat than the control group. The design can't separate avocado from mango, can't show that the two work better together, and didn't establish what drove the vessel change.
| Evidence | Foods and comparison | FMD finding | What it establishes |
|---|---|---|---|
| 2024 HAT vascular trial, 134 adults with abdominal obesity, six months | One avocado daily versus habitual diet | No significant difference | Avocado added to a usual diet showed no significant FMD benefit in this group |
| 2026 prediabetes trial, 82 adults, eight weeks | Avocado plus mango daily versus calorie-matched low-fiber foods | Improved relative to control, partly because control declined | An unreplicated signal for this pair in prediabetes |
These studies differ in who was enrolled, how long they ran, and what the fruit was compared against, so the avocado-only null result doesn't refute the new trial. One plausible reading is that the comparison food matters a lot: avocado against people's usual diet showed no significant FMD benefit, while avocado and mango against refined, low-fiber foods showed a benefit. That reading points toward the swap itself as the useful part, though it hasn't been tested directly.
What didn't move
Fasting blood sugar, cholesterol, and inflammation markers didn't differ significantly between groups. A nonsignificant result doesn't rule out a small effect. Still, nothing here supports expecting your glucose to fall.
Body weight stayed stable, but that happened under calorie-matched conditions. An avocado and a cup of mango carry real calories, and the trial doesn't tell you what happens if you add them on top of everything else you eat. Men in the fruit group also had lower diastolic blood pressure than men on the control diet, mostly because pressure rose in the control group. That was an exploratory subgroup finding, so it's a lead for future trials and not a benefit to count on.
Using the finding if you have prediabetes
The American Diabetes Association's 2026 Standards already recommend whole fruits for people with prediabetes, within meal plans that account for calories and metabolic goals, while limiting refined grains, sweets, and highly processed foods. This trial fits that advice and adds a randomized vessel signal, which matters to you because prediabetes is associated with higher cardiovascular risk. Treat one avocado plus one cup of mango as the amount studied, which doesn't make it the optimal dose or a daily requirement. For adults with prediabetes and overweight, the ADA's central recommendation is still a structured prevention program built around sustained weight loss, fewer calories, and regular moderate exercise, and this swap can sit inside that plan.
Prediabetes is worth tracking at least once a year, per the ADA, and fasting glucose and hemoglobin A1c are tests you can order yourself. If you make the swap, retesting will show whether your own numbers move, keeping in mind that this trial found no significant fasting-glucose benefit in eight weeks.
Confidence would grow with an independent, larger, and longer trial that reproduces the vessel benefit and handles missing data well. A trial comparing avocado alone, mango alone, the combination, and another nutrient-rich replacement food would test whether this pair offers anything special. Claims about preventing diabetes or heart disease would need trials that measure those outcomes, and this trial did not.

